Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling

Transplantation Proceedings · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles